HIV vaccine research and human rights: examples from three countries planning efficacy trials.
The protection of human rights will be critical to the success of HIV vaccine trials throughout the world. A vaccine for HIV remains our best hope to control the global epidemic. In order to launch and sustain useful and successful human trials of HIV vaccines, a partnership between scientists, governments, pharmaceutical companies, and affected communities is essential. This article provides a review of some of the key issues relevant to human rights in the design, testing, and dissemination of HIV vaccines. The article gives specific examples from three countries -- Brazil, Thailand, and the United States -- which may initiate large-scale trials in the near future.
Beloqui
Jorge
J
Chokevivat
Vichai
V
Collins
Chris
C
D001938:Brazil; D035881:Compensation and Redress; D003695:Delivery of Health Care; D003906:Developing Countries; D004345:Drug Industry; D004467:Economics; D026724:Ethical Review; D004989:Ethics; D006679:HIV Seropositivity; D006805:Human Experimentation; D006806:Human Rights; D006801:Humans; D007114:Immunization; D007391:International Cooperation; D038622:Internationality; D011287:Prejudice; D011315:Preventive Medicine; D011640:Public Policy; D012106:Research; D012107:Research Design; D035842:Research Subjects; D012306:Risk; D018570:Risk Assessment; D012935:Social Justice; D013240:Stereotyping; D013785:Thailand; D036302:Therapeutic Human Experimentation; D014838:Volunteers; D014947:Wounds and Injuries